240 related articles for article (PubMed ID: 27957684)
41. Atypical ubiquitination by E3 ligase WWP1 inhibits the proteasome-mediated degradation of mutant huntingtin.
Lin L; Jin Z; Tan H; Xu Q; Peng T; Li H
Brain Res; 2016 Jul; 1643():103-12. PubMed ID: 27107943
[TBL] [Abstract][Full Text] [Related]
42. The mGluR5 positive allosteric modulator, CDPPB, ameliorates pathology and phenotypic signs of a mouse model of Huntington's disease.
Doria JG; de Souza JM; Andrade JN; Rodrigues HA; Guimaraes IM; Carvalho TG; Guatimosim C; Dobransky T; Ribeiro FM
Neurobiol Dis; 2015 Jan; 73():163-73. PubMed ID: 25160573
[TBL] [Abstract][Full Text] [Related]
43. Phylogenetic comparison of huntingtin homologues reveals the appearance of a primitive polyQ in sea urchin.
Tartari M; Gissi C; Lo Sardo V; Zuccato C; Picardi E; Pesole G; Cattaneo E
Mol Biol Evol; 2008 Feb; 25(2):330-8. PubMed ID: 18048403
[TBL] [Abstract][Full Text] [Related]
44. Intersectin enhances huntingtin aggregation and neurodegeneration through activation of c-Jun-NH2-terminal kinase.
Scappini E; Koh TW; Martin NP; O'Bryan JP
Hum Mol Genet; 2007 Aug; 16(15):1862-71. PubMed ID: 17550941
[TBL] [Abstract][Full Text] [Related]
45. Resveratrol protects neuronal-like cells expressing mutant Huntingtin from dopamine toxicity by rescuing ATG4-mediated autophagosome formation.
Vidoni C; Secomandi E; Castiglioni A; Melone MAB; Isidoro C
Neurochem Int; 2018 Jul; 117():174-187. PubMed ID: 28532681
[TBL] [Abstract][Full Text] [Related]
46. [Huntington's disease: cellular and molecular basis of pathology].
Korzhova VV; Artamonov DN; Vlasova OL; Bezprozvannyĭ IB
Zh Vyssh Nerv Deiat Im I P Pavlova; 2014; 64(4):359-75. PubMed ID: 25723022
[TBL] [Abstract][Full Text] [Related]
47. Quercetin improves the activity of the ubiquitin-proteasomal system in 150Q mutated huntingtin-expressing cells but exerts detrimental effects on neuronal survivability.
Chakraborty J; Rajamma U; Jana N; Mohanakumar KP
J Neurosci Res; 2015 Oct; 93(10):1581-91. PubMed ID: 26153070
[TBL] [Abstract][Full Text] [Related]
48. The Biology of Huntingtin.
Saudou F; Humbert S
Neuron; 2016 Mar; 89(5):910-26. PubMed ID: 26938440
[TBL] [Abstract][Full Text] [Related]
49. TAT-mediated delivery of neuroglobin attenuates apoptosis induced by oxygen-glucose deprivation via the Jak2/Stat3 pathway in vitro.
Lin Y; Cai B; Xue XH; Fang L; Wu ZY; Wang N
Neurol Res; 2015 Jun; 37(6):531-8. PubMed ID: 25023896
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of apoptosis signal-regulating kinase 1 reduces endoplasmic reticulum stress and nuclear huntingtin fragments in a mouse model of Huntington disease.
Cho KJ; Lee BI; Cheon SY; Kim HW; Kim HJ; Kim GW
Neuroscience; 2009 Nov; 163(4):1128-34. PubMed ID: 19646509
[TBL] [Abstract][Full Text] [Related]
51. Wild-type huntingtin ameliorates striatal neuronal atrophy but does not prevent other abnormalities in the YAC128 mouse model of Huntington disease.
Van Raamsdonk JM; Pearson J; Murphy Z; Hayden MR; Leavitt BR
BMC Neurosci; 2006 Dec; 7():80. PubMed ID: 17147801
[TBL] [Abstract][Full Text] [Related]
52. AMPK-α1 functions downstream of oxidative stress to mediate neuronal atrophy in Huntington's disease.
Ju TC; Chen HM; Chen YC; Chang CP; Chang C; Chern Y
Biochim Biophys Acta; 2014 Sep; 1842(9):1668-80. PubMed ID: 24946181
[TBL] [Abstract][Full Text] [Related]
53. Effects of intracellular expression of anti-huntingtin antibodies of various specificities on mutant huntingtin aggregation and toxicity.
Khoshnan A; Ko J; Patterson PH
Proc Natl Acad Sci U S A; 2002 Jan; 99(2):1002-7. PubMed ID: 11792860
[TBL] [Abstract][Full Text] [Related]
54. The role of neuroglobin in the neuroprotection of limb ischemic preconditioning in rats.
Li SQ; Li WB; Zhang M; Wu YZ; Hu YY
Mol Neurobiol; 2013 Feb; 47(1):197-208. PubMed ID: 23180278
[TBL] [Abstract][Full Text] [Related]
55. Establishment of Cell-Based Neuroglobin Promoter Reporter Assay for Neuroprotective Compounds Screening.
Liu N; Yu Z; Gao X; Song YS; Yuan J; Xun Y; Wang T; Yan F; Yuan S; Zhang J; Xiang S; Lo EH; Wang X
CNS Neurol Disord Drug Targets; 2016; 15(5):629-39. PubMed ID: 26996171
[TBL] [Abstract][Full Text] [Related]
56. Neuroglobin As Key Mediator in the 17β-Estradiol-Induced Antioxidant Cell Response to Oxidative Stress.
Solar Fernandez V; Cipolletti M; Ascenzi P; Marino M; Fiocchetti M
Antioxid Redox Signal; 2020 Feb; 32(4):217-227. PubMed ID: 31686530
[No Abstract] [Full Text] [Related]
57. Huntingtin is required for normal excitatory synapse development in cortical and striatal circuits.
McKinstry SU; Karadeniz YB; Worthington AK; Hayrapetyan VY; Ozlu MI; Serafin-Molina K; Risher WC; Ustunkaya T; Dragatsis I; Zeitlin S; Yin HH; Eroglu C
J Neurosci; 2014 Jul; 34(28):9455-72. PubMed ID: 25009276
[TBL] [Abstract][Full Text] [Related]
58. Neuroglobin overexpression plays a pivotal role in neuroprotection through mitochondrial raft-like microdomains in neuroblastoma SK-N-BE2 cells.
Garofalo T; Ferri A; Sorice M; Azmoon P; Grasso M; Mattei V; Capozzi A; Manganelli V; Misasi R
Mol Cell Neurosci; 2018 Apr; 88():167-176. PubMed ID: 29378245
[TBL] [Abstract][Full Text] [Related]
59. Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin.
Morfini GA; You YM; Pollema SL; Kaminska A; Liu K; Yoshioka K; Björkblom B; Coffey ET; Bagnato C; Han D; Huang CF; Banker G; Pigino G; Brady ST
Nat Neurosci; 2009 Jul; 12(7):864-71. PubMed ID: 19525941
[TBL] [Abstract][Full Text] [Related]
60. Striatal Projection Neurons Require Huntingtin for Synaptic Connectivity and Survival.
Burrus CJ; McKinstry SU; Kim N; Ozlu MI; Santoki AV; Fang FY; Ma A; Karadeniz YB; Worthington AK; Dragatsis I; Zeitlin S; Yin HH; Eroglu C
Cell Rep; 2020 Jan; 30(3):642-657.e6. PubMed ID: 31968243
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
